Kiora Pharmaceuticals, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery

Other Names/Subsidiaries

  • EyeGate Pharma S.A.S.
  • Jade Therapeutics, Inc.
  • Optis France S.A.
  • Panoptes Pharma GmbH
  • EyeGate Pharmaceuticals, Inc.
See more in Biomedtracker

Latest on Kiora Pharmaceuticals, Inc.

Scrip

Deal Watch: Bristol To Link Up With VantAI On Molecular Glue Therapies

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr

Scrip

Deal Watch: Celgene CVR From BMS Buyout Falls Through

 
• By Joseph Haas, Anju Ghangurde, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Site Inspection Issue Quashes Bristol/C

Scrip

Eight Pivotal Trial Read-Outs Expected In Q3

 
• By Alex Shimmings

Redhill Biopharma's RHB-104 For Crohn's Disease RedHill Biopharma Ltd. is in August 2018 expected to report unblinded top-line results from the Phase III MAP US study of RHB-104, an oral antibiotic

Scrip

Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer

 
• By Mandy Jackson

The obesity market has not generated any blockbuster success stories for the biopharmaceutical industry, but Vivus Inc. still sells the prescription weight loss drug Qsymia (phentermine and topira